The Yield of Dysplasia and Serrated Lesions in a Single-centre Tertiary Inflammatory Bowel Disease Cohort

Overview

Journal Therap Adv Gastroenterol

Publisher Sage Publications

Specialty Gastroenterology

Date 2023 May 8

PMID 37153500

Authors

Fiona Yeaman

Lena Thin

Affiliations

Soon will be listed here.

Abstract

Background: Chromoendoscopy is preferred over high-definition white light endoscopy (HDWLE) for dysplasia surveillance in inflammatory bowel disease (IBD) patients, but is more time-consuming to perform and real-world evidence is limited. The prevalence of sessile serrated lesions (SSLs) in IBD patients is also unknown.

Objective: To determine the yield of polypoid and non-polypoid dysplasia and SSLs in IBD patients undergoing dysplasia surveillance and the associations for these lesions.

Design: A retrospective cohort study from a tertiary IBD centre.

Methods: A keyword search of the colonoscopy reporting system was performed. IBD patients with colonic disease that underwent colonoscopy for surveillance between 1 February 2015 and 1 February 2018 were included. Clinical, endoscopic and histopathological outcomes were extracted for the analysis.

Results: Of 2114 patients identified, 276 eligible colonoscopies in 126 patients were analysed. The median age at colonoscopy was 51 years (interquartile range: 42-58 years). 71/126 (56%) of colonoscopies were performed in male patients, with 57/126 (45%) having ulcerative colitis, 68/126 (54%) Crohn's colitis and 1/126 (0.79%) IBD-unspecified. The prevalence for any neoplasia was 75/276 (27%). The prevalence for all serrated lesions was 43/276 (16%). Increased age was a risk factor for finding a neoplastic lesion on both univariate and multivariate analyses. Chromoendoscopy was associated with twice the odds of finding a neoplastic lesion (odds ratio: 1.99, 95% confidence interval: 1.13-3.51, = 0.02), on multivariate analysis. No factor was associated with an increased risk of finding a serrated lesion.

Conclusion: Significant neoplastic lesions and serrated lesions were detected in 27% and 16% of colonoscopies performed in IBD patients, respectively, with the highest yield in older patients. Chromoendoscopy significantly increased neoplasia yield compared to HDWLE and still has a robust utility in this pragmatic real-world study.

Citing Articles

Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD.

Motta R, Gupta V, Hartery K, Bassett P, Leedham S, Chapman R Endosc Int Open. 2024; 12(11):E1285-E1294.

PMID: 39534278 PMC: 11555309. DOI: 10.1055/a-2437-8102.

References

Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M . Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004; 126(2):451-9. DOI: 10.1053/j.gastro.2003.11.010. View

Romano M, De Francesco F, Zarantonello L, Ruffolo C, Ferraro G, Zanus G . From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives. Anticancer Res. 2016; 36(4):1447-60. View

Parian A, Lazarev M . Serrated Colorectal Lesions in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2018; 14(1):19-25. PMC: 5824591. View

de Jong M, Nagtegaal I, Vos S, van der Post R, van Herwaarden Y, Derikx L . Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia. Dig Dis Sci. 2022; 67(12):5647-5656. PMC: 9652229. DOI: 10.1007/s10620-022-07485-w. View

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453-7. DOI: 10.1016/S0140-6736(07)61602-X. View

Kim J, Kang G . Evolving pathologic concepts of serrated lesions of the colorectum. J Pathol Transl Med. 2020; 54(4):276-289. PMC: 7385269. DOI: 10.4132/jptm.2020.04.15. View

Wan J, Zhang Q, Liang S, Zhong J, Li J, Ran Z . Chromoendoscopy with targeted biopsies is superior to white-light endoscopy for the long-term follow-up detection of dysplasia in ulcerative colitis patients: a multicenter randomized-controlled trial. Gastroenterol Rep (Oxf). 2021; 9(1):14-21. PMC: 7962735. DOI: 10.1093/gastro/goaa028. View

Yang D, Park S, Kim H, Park Y, Park D, Lee K . High-Definition Chromoendoscopy Versus High-Definition White Light Colonoscopy for Neoplasia Surveillance in Ulcerative Colitis: A Randomized Controlled Trial. Am J Gastroenterol. 2019; 114(10):1642-1648. DOI: 10.14309/ajg.0000000000000341. View

Saraiva S, Rosa I, Moleiro J, Pereira da Silva J, Fonseca R, Dias Pereira A . Dysplasia Surveillance in Inflammatory Bowel Disease: A Cohort Study. GE Port J Gastroenterol. 2021; 28(2):97-105. PMC: 7991274. DOI: 10.1159/000510728. View

10.

Alexandersson B, Hamad Y, Andreasson A, Rubio C, Ando Y, Tanaka K . High-Definition Chromoendoscopy Superior to High-Definition White-Light Endoscopy in Surveillance of Inflammatory Bowel Diseases in a Randomized Trial. Clin Gastroenterol Hepatol. 2020; 18(9):2101-2107. DOI: 10.1016/j.cgh.2020.04.049. View

11.

Ekbom A, HELMICK C, Zack M, Adami H . Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990; 336(8711):357-9. DOI: 10.1016/0140-6736(90)91889-i. View

12.

Lee H, Rabinovitch P, Mattis A, Lauwers G, Choi W . Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia. Histopathology. 2020; 78(6):814-830. DOI: 10.1111/his.14298. View

13.

Murthy S, Feuerstein J, Nguyen G, Velayos F . AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review. Gastroenterology. 2021; 161(3):1043-1051.e4. DOI: 10.1053/j.gastro.2021.05.063. View

14.

Rex D, Ahnen D, Baron J, Batts K, Burke C, Burt R . Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012; 107(9):1315-29. PMC: 3629844. DOI: 10.1038/ajg.2012.161. View

15.

Farraye F, Odze R, Eaden J, Itzkowitz S, McCabe R, Dassopoulos T . AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010; 138(2):738-45. DOI: 10.1053/j.gastro.2009.12.037. View

16.

Eaden J, Abrams K, Mayberry J . The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001; 48(4):526-35. PMC: 1728259. DOI: 10.1136/gut.48.4.526. View

17.

Askling J, Dickman P, Karlen P, Brostrom O, Lapidus A, Lofberg R . Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001; 120(6):1356-62. DOI: 10.1053/gast.2001.24052. View

18.

Johnson D, Khanna S, Smyrk T, Loftus Jr E, Anderson K, Mahoney D . Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis. Aliment Pharmacol Ther. 2014; 39(12):1408-17. PMC: 4894660. DOI: 10.1111/apt.12774. View

19.

Galler Rabinowitz L, Kumta N, Marion J . Beyond the SCENIC route: updates in chromoendoscopy and dysplasia screening in patients with inflammatory bowel disease. Gastrointest Endosc. 2021; 95(1):30-37. DOI: 10.1016/j.gie.2021.07.024. View

20.

IJspeert J, Bevan R, Senore C, Kaminski M, Kuipers E, Mroz A . Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview. Gut. 2016; 66(7):1225-1232. DOI: 10.1136/gutjnl-2015-310784. View